Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Renal Cell Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07776483
What this trial is testing

Personalized ctDNA Monitoring for Predicting Immunotherapy Outcomes in Advanced Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Non-Clear Cell Renal Cell Carcinoma
West China Hospital 67
Not applicableNot Yet RecruitingNCT07500831
What this trial is testing

Fasting-Mimicking Diet Combined With IO-TKI Combination Therapy in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal CellMetastatic Renal Cell CarcinomaAdvanced Renal Cell Carcinoma
Qilu Hospital of Shandong University 43
Early research (Phase 1)UnknownNCT05420545
What this trial is testing

A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

Who this might be right for
Metastatic TumorAdvanced Solid TumorRenal Cell Carcinoma+2 more
Chongqing Precision Biotech Co., Ltd 36
Early research (Phase 1)Study completedNCT00120939
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more
Pharmacyclics LLC. 25
Early research (Phase 1)Study completedNCT00622674
What this trial is testing

Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+5 more
Masonic Cancer Center, University of Minnesota 37
Not applicableStudy completedNCT04957160
What this trial is testing

Cabozantinib Post First-line Immuno-oncology Checkpoint Inhibitor Containing Combination

Who this might be right for
Advanced Renal Cell Carcinoma (aRCC)
Ipsen 281
Not applicableStudy completedNCT03519542
What this trial is testing

Epidemiological Study to Identify Prognosis and Predictive Biomarkers for Advanced or Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Spanish Oncology Genito-Urinary Group 62
Not applicableStudy completedNCT03948724
What this trial is testing

Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology

Who this might be right for
Therapeutic Patient EducationImmune Checkpoint InhibitorsMelanoma+4 more
Institut Cancerologie de l'Ouest 412
Testing effectiveness (Phase 2)Study completedNCT05877820
What this trial is testing

Evaluate Efficacy and Safety of Lenvatinib Combined With Tislelizumab in Patients With FHRCC

Who this might be right for
Fumarate Hydratase Deficient Renal Cell Carcinoma
RenJi Hospital 20
Early research (Phase 1)Ended earlyNCT04691375
What this trial is testing

PY314 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorGynecologic CancerBreast Cancer+6 more
Ikena Oncology 86
Early research (Phase 1)Study completedNCT03538028
What this trial is testing

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

Who this might be right for
Cervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more
Incyte Biosciences International Sàrl 22
Testing effectiveness (Phase 2)Study completedNCT02843607
What this trial is testing

Combination of Cryosurgery and NK Immunotherapy for Advanced Kidney Cancer

Who this might be right for
Metastatic Renal Cell Cancer
Fuda Cancer Hospital, Guangzhou 30
Testing effectiveness (Phase 2)UnknownNCT04903873
What this trial is testing

Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors

Who this might be right for
Solid TumorRenal Cell Cancer MetastaticNon-Small Cell Lung Cancer+2 more
Eutilex 110
Testing effectiveness (Phase 2)UnknownNCT05485883
What this trial is testing

Tislelizumab Plus Lenvatinib in Stage III-IV RCC

Who this might be right for
Advanced Kidney Cancer
Tianjin Medical University Second Hospital 20
Testing effectiveness (Phase 2)UnknownNCT02072031
What this trial is testing

Phase II Study of Anlotinib Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma（RCC）

Who this might be right for
AnlotinibRCC
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 133
Not applicableStudy completedNCT01404104
What this trial is testing

Neo-adjuvant Temsirolimus in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
St. Joseph's Healthcare Hamilton 11
Early research (Phase 1)Not Yet RecruitingNCT07500805
What this trial is testing

UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma

Who this might be right for
CD70-positive Advanced Renal Clear Cell Carcinoma
UTC Therapeutics Inc. 21
Testing effectiveness (Phase 2)UnknownNCT05124431
What this trial is testing

Anlotinib Plus Everolimus as First-line Treatment for Advanced Non Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Fudan University 30
Testing effectiveness (Phase 2)Ended earlyNCT02959554
What this trial is testing

Study in Which Therapy is Either Switched to Nivolumab After 3 Months of Treatment or Therapy is Continued With a Tyrosine Kinase Inhibitor in Patients With Metastatic Renal Cell Carcinoma (RCC) and Disease Control

Who this might be right for
Metastatic Renal Cell Carcinoma
AIO-Studien-gGmbH 49
Large-scale testing (Phase 3)Active Not RecruitingNCT03937219
What this trial is testing

Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Exelixis 855
Next Page